B007 not checked

Shanghai Jiaolian Drug Research and Development Co., Ltd

FollowEvery change as it happens, and a Monday email
Stage
 
Next date
Phase 2/3 trial completes
Trials
4 active
4 in total
Targets
 

What this is

How it works
How it works isn't classified yet
How it’s given
“B007 high dose and low dose: Subcutaneous injection was administered on days 1 and 15”In the company’s words, NCT06447597 on ClinicalTrials.gov
Tested for
Primary Membranous Nephropathy (2 trials), Generalized Myasthenia Gravis, Pemphigus
Main trialPhase 2/3
“The purpose of this study is to evaluate the efficacy and safety of B007 in subjects with generalized myasthenia gravis.”In the company’s words, NCT06447597 on ClinicalTrials.gov

Other drugs for Primary Membranous Nephropathy

All 369 drugs for Primary Membranous Nephropathy

Coming up4

Changes0

Last 90 days

No changes yet. We started recording changes on 6 Nov 2026.

Trials4

TrialPhaseCompletesWhat it tests
Phase 2/3Recruiting 30 Dec 2026 A Clinical Study of B007 in the Treatment of Generalized Myasthenia Gravis.
Phase 2/3Recruiting 31 Dec 2026 A Clinical Study of B007 in the Treatment of Pemphigus.
Phase 2/3Recruiting 31 Dec 2026 A Clinical Study of B007 in the Treatment of Primary Membranous Nephropathy.
Phase 1Recruiting 30 Dec 2026 A Phase I Clinical Study of Recombinant Humanized Anti-CD20(B-lymphocyte Antigen CD20) Monoclonal Antibody Subcutaneous Injection in the Treatment of Primary Membranous Nephropathy
A trial in both registries shows both numbers.

About

Sources
ClinicalTrials.gov updated 18 Nov 2026 · EU trials register (CTIS) updated 18 Nov 2026 · openFDA updated 17 Nov 2026

Follow B007

Following is part of Solo: you see every change to B007 the day it happens.

Solo

$49a month, excl. VAT

  • Follow up to 5 landscapes, companies or drugs
  • Every change, the day it happens
  • A Monday email with the week’s changes
Choose Solo

Free

$0no card

  • One landscape of your own, in full
  • The top 10 of everything else
Sign up free

Have an account? Sign in